Hap Trading, LLC Kala Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 10, 2021	SELL	$2.62 - $5.43 $54,234 - $112,401	-20,700 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$5.06 - $8.15 $88,044 - $141,810	-17,400 Reduced 45.67%	20,700 $4,000
Q1 2021 May 14, 2021	SELL	$6.24 - $9.58 $79,872 - $122,624	-12,800 Reduced 25.15%	38,100 $16,000
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $218,544 - $305,891	34,800 Added 216.15%	50,900 $37,000
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $8,250 - $12,221	-1,100 Reduced 6.4%	16,100 $17,000
Q2 2020 Aug 10, 2020	SELL	$8.33 - $13.79 $15,827 - $26,201	-1,900 Reduced 9.95%	17,200 $38,000
Q1 2020 May 08, 2020	BUY	$3.83 - $8.79 $73,153 - $167,888	19,100 New	19,100 $34,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.69M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.